This inventor holds 202 USPTO granted patents and 66 published patent applications and 9 EPO patents, primarily in Ophthalmic Surgery (CPC class A61F9-0017). Top assignees: University of Southern California, California Institute of Technology, Second Sight Medical Products, Inc.. Active years: 1999-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Baltimore, MD (US) (1999)
- Glandale, CA (US) (2011)
- La Canada Flintridge, CA (US) (2011)
- La Canada, CA (US) (2004 - 2012)
- Timonium, MD (US) (2006 - 2012)
- Los Angeles, CA (US) (2010 - 2020)
- Glendale, CA (US) (2006 - 2024)
Company Filing History:
64 out of 1,694 
44 out of 4,626 
43 out of 347 
Years Active: 1999-2025
Areas of Expertise:
Title: Mark Salman Humayun: Innovating Artificial Vision Systems
Introduction:
Mark Salman Humayun, a brilliant inventor and researcher based in Glendale, CA, has made significant contributions to the field of ophthalmology and artificial vision systems. With a remarkable portfolio of 186 patents, Humayun's groundbreaking work has revolutionized the way we understand and treat ocular diseases. This article explores the highlights of his career, his latest patents, and notable collaborations.
Latest Patents:
Among his notable recent patents, Humayun has developed an ingenious Tear Flow Measurement Device. This device utilizes a polymer microcapillary tube coated on one end with soft silicone rubber and treated on the inside to be hydrophobic. With the ability to collect and analyze tear fluid, this invention offers new possibilities for assessing eye health.
Humayun has also pioneered a method of cryopreservation of stem cell-derived retinal pigment epithelial cells on a polymeric substrate. By preserving these vital cells, this breakthrough has immensely contributed to the development of cell therapies for ocular damage and disease.
Career Highlights:
Humayun's career is a testament to his dedication and expertise in the field. He has been associated with renowned institutions such as the University of Southern California, where he has made significant advancements in the field of ophthalmology. His work has helped bridge the gap between research and clinical applications, bringing new hope to patients suffering from ocular conditions.
Collaborations:
Humayun's collaborations with esteemed colleagues have further enhanced his contributions to the field. One notable collaborator is Yu-Chong Tai, an accomplished scientist and engineer, with whom Humayun has worked closely. Tai's expertise in micro and nanotechnology has greatly complemented Humayun's work in developing innovative medical devices.
Another significant collaboration for Humayun has been with Robert Jay Greenberg, a fellow visionary in the field of ophthalmology. Together, they have explored cutting-edge technologies and pioneered groundbreaking solutions for ocular diseases.
Conclusion:
Mark Salman Humayun's relentless pursuit of innovation has resulted in numerous advancements in the field of artificial vision systems. With his groundbreaking Tear Flow Measurement Device and cryopreservation methods, Humayun has unlocked new possibilities for evaluating eye health and developing effective treatments. Collaborations with esteemed individuals like Yu-Chong Tai and Robert Jay Greenberg have further amplified his impact on the field. We eagerly anticipate the future contributions of this exceptional inventor, whose work continues to transform the lives of countless individuals with ocular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile